Eisai, Biogen receives U.S. FDA approval for Alzheimer’s drug, applies for full approval January 7, 2023
Eisai, Biogen say Alzheimer’s drug succeeds in slowing cognitive decline September 28, 2022September 28, 2022
FDA offers Biogen, Eisai a shortcut to a possible lecanemab approval – Endpoints News July 6, 2022July 6, 2022